Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents (Q45370648)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 19, 2010

Language	Label	Description	Also known as
English	Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents	scientific article published on November 19, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents (English)

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1

object named as

Rui-Hua Guo

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

6

object named as

Li-Jun Wang

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21145140

19 November 2024

author name string

Quan Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yun-Bao Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jie Luo

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Chang-An Geng

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Xue-Mei Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jun Zhou

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Zhi-Yong Jiang

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Ji-Jun Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21145140

19 November 2024

publication date

19 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0223523410008147?httpAccept=text/xml

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

https://api.elsevier.com/content/article/PII:S0223523410008147?httpAccept=text/plain

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

European Journal of Medicinal Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

307-319

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion

2

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

3

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Chronic hepatitis B in hepatocarcinogenesis

4

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

5

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Hepatitis B virus infection: current status

6

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Review article: current antiviral therapy of chronic hepatitis B.

7

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitors of hepatitis B virus

9

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

10

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Periglaucines A-D, anti-HBV and -HIV-1 alkaloids from Pericampylus glaucus

11

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives

12

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors

13

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives

14

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Swerilactones A and B, anti-HBV new lactones from a traditional Chinese herb: Swertia mileensis as a treatment for viral hepatitis

15

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors

16

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Inhibitors of plasmin that extend into both the S and S' binding sites: cooperative interactions between S1 and S2.

18

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

A novel synthesis of acyclonucleosides via allylation of 3-[1-(phenylhydrazono)-L-threo-2,3,4-trihydroxybut-1-yl]quinoxalin-2(1H)one

19

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase.

20

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Asymmetric lithiation-substitution sequences of substituted allylamines

21

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein

22

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Regulation of hepatitis B virus gene expression by its two enhancers

23

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Regulatory elements of hepatitis B virus transcription

24

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Inhibition of hepatitis B virus surface antigen expression by small hairpin RNA in vitro

25

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients

26

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Cultivation of HepG2.2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods.

27

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis

28

1 reference

10.1016/J.EJMECH.2010.11.019

https://api.crossref.org/works/10.1016/J.EJMECH.2010.11.019

19 November 2024

Identifiers

10.1016/J.EJMECH.2010.11.019

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45370648&oldid=2277121577"